GliaSite radiation therapy system approved by the US Food and Drug Administration (FDA) is an internal radiation delivery system for brain tumors. The system consisting of an inflatable balloon containing a liquid form of the radioactive material that delivers radiation to the edges of the tumor cavity, where some cancerous cells may remain.
Go to Previous Page
Go to Next Page